The effect of acetazolamide on athletic performance at height

Effect of acetazolamide on exercise performance of male physical education students in simulated altitude

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170326033146N6

Enrollment

Registered

2021-04-08

Start date

2021-04-21

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxia.

Interventions

Intervention 1: Supplementary group: First, a cognitive function test will be performed. 48 hours later, subjects will take 2 doses of 125 mg and another dose the next morning of acetazolamide. The As

Eligibility

Sex/Gender

Male

Age

18 Years to 29 Years

Inclusion criteria

Inclusion criteria: Male student of Razi University 18 to 29 years old BMI: 18.5 - 29.4

Exclusion criteria

Exclusion criteria: Permanent residence at altitudes above 2000 meters History of cognitive disorders or neurological diseases Having a chronic illness Smoking History of living at altitudes of more than 2000 meters in the two months before the start of a research

Design outcomes

Primary

Measure	Time frame
Endurance training performance. Timepoint: The beginning of the study to assess the level of endurance function after taking acetazolamide or placebo and after hypoxia. Method of measurement: The Astrand test for men is used to measure the maximum power output of the subjects.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahid Tadibi

Razi University

vtadibi@yahoo.com+98 83 3427 9265

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026